glp 1 agonist saxenda (liraglutide) Novo Nordisk announces Saxenda® (liraglutide
Description
Effects of semaglutide on stroke subtypes in type 2 diabetes: post hoc analysis of the randomized SUSTAIN 6 and PIONEER 6
After 26 weeks, along with a greater change in HbA1c from baseline, no changes in renal function were observed with liraglutide when compared to placebo
Nature 546 , 248253 (2017)
A study involving 966 patients on statins during exenatide trials found that lipid-lowering effects were comparable to those in the placebo group 51% were on atorvastatin, and 31% on simvastatin
Health Drug Benefits
[DOI] [PMC free article] [PubMed] [Google Scholar] 84
